|
SNDX Syndax Pharmaceuticals Inc 1395937 |
| Balance Sheet |
|
Current Assets
|
$675,039,000.00 |
|
Assets
|
$703,652,000.00 |
|
Current Liabilities
|
$99,677,000.00 |
|
Liabilities
|
$688,553,000.00 |
|
Equity
|
$15,099,000.00 |
|
Shares Out
|
89150619.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-80,617,000.00 |
|
Investing Cash Flow
|
$21,476,000.00 |
| Market Analysis |
Market Cap
|
$1,760,724,725.25 |
|
Price
|
$19.75 |
|
BVPS
|
0.17 |
|
PB
|
116.18 |
|
EPS
|
-0.55 |
|
PS
|
6.05 |
|
FCF
|
$-80,804,000.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-09-01 09:32:31 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-09-14 10:01:22 |
|
| Jan |
Feb |
Mar |
|
|
|
|
2026-02-26 |
-0.78 |
|
| Apr |
May |
Jun |
|
|
2026-04-30 |
0.48 |
|
|
|
| Jul |
Aug |
Sep |
|
|
|
|
2025-08-04 |
-0.83 |
|
| Oct |
Nov |
Dec |
|
|
|
|
2025-11-03 |
-0.70 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view SNDX documents filed with the SEC.
SNDX Filings
Clear
